SS

Sheldon Sloan

DELAYED 1 MONTH

Chief Medical Officer

Spyre Therapeutics, Inc.

Filings

2

Companies

1

Latest

Jun 3, 2026

Transactions

Signal

Ticker / Company

Insider

Transaction

Value

Filed

78
SYRECLUSTER 4FULL EXIT

Spyre Therapeutics, Inc.

Sheldon Sloan

Chief Medical Officer

Sale

$625.0K

8,333 sh

Jun 4 1:32 AM

Jun 3, 2026

—

Spyre Therapeutics, Inc.

Sheldon Sloan

Chief Medical Officer

Option Exercise

$228.8K

8,333 sh

Jun 4 1:32 AM

Jun 3, 2026

82
SYRECLUSTER 3FULL EXIT

Spyre Therapeutics, Inc.

Sheldon Sloan

Chief Medical Officer

Sale

$5.6M

78,333 sh

May 2 1:34 AM

May 1, 2026

—

Spyre Therapeutics, Inc.

Sheldon Sloan

Chief Medical Officer

Option Exercise

$2.2M

78,333 sh

May 2 1:34 AM

May 1, 2026